Search For "central drugs standard"
CDSCO issues advisory to curb misleading promotion of prescription medicat
Updated : 4 months, 2 weeks ago IST
The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 in the promotion and marketin
Read More
Over 200 drugs identified to be not of standard quality in CDSCO list for
Updated : 7 months, 2 weeks ago IST
The Central Drugs Standard Control Organisation (CDSCO) on Friday released the list of Not of Standard Quality (NSQ) and Spurious drugs for November 2025 on its portal, according to a release.
Read More
Lords Mark Renalyx Wins Licence to Make Class C World's First AI-Based Sma
Updated : 7 months, 3 weeks ago IST
New Delhi [India], December 10: Lords Mark Industries Ltd. (LMIL) has achieved a defining milestone in India's med-tech landscape by receiving the licence to manufacture Class C World's First AI-Based Smart HemodialysisMachines from the Central Drugs Standard Control Organisation (CDSCO), a
Read More
Centre to bring new drug law following Madhya Pradesh cough syrup tragedy
Updated : 9 months, 2 weeks ago IST
A new law is being proposed to grant statutory powers to the Central Drugs Standard Control Organisation (CDSCO) to regulate the manufacture, distribution, and sale of drugs, medical devices, and cosmetics.
Read More
CDSCO to come up with robust system to keep check on cough syrup manufactu
Updated : 9 months, 3 weeks ago IST
The Central Drugs Standard Control Organisation (CDSCO) sought a list of all cough manufacturing companies from all States. According to the sources, the CDSCO will conduct inspections, testing, and audits of all companies manufacturing cough syrup.
Read More
Made in India: Agatsa Launches EasyTouch+ - India's First Smart, Prickless
Updated : 11 months, 2 weeks ago IST
New Delhi [India], August 20: For millions of Indians living with diabetes, the daily reality of monitoring blood sugar comes with an uncomfortable routine -sharp needle pricks, recurring costs for strips, and the constant reminder of the condition. Agatsa, a pioneering Indian health technol
Read More
Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Wo
Updated : 11 months, 3 weeks ago IST
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) f
Read More
Servier India introduces 'Ivosidenib'(Tibsovo®), in India, First-in-c
Updated : 1 year, 1 month ago IST
Mumbai (Maharashtra) [India], June 5: Servier India, a subsidiary of the leading French pharmaceutical Servier Group, today announced the launch of Ivosidenib (Tibsovo®), an oral targeted therapy approved in the management of cancer patients with Acute Myeloid Leukemia (AML) and Cholang
Read More
Uttarakhand takes steps for environmentally responsible disposal of medic
Updated : 1 year, 2 months ago IST
Chief Minister Pushkar Singh Dhami has started work towards implementing the guidelines issued by the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, Government of India in the state.
Read More
CDSCO "urgently" orders halt on production of 35 unapproved combination dr
Updated : 10 months ago IST
The Central Drugs Standard Control Organisation (CDSCO) has issued an urgent directive to all state and Union Territory drug controllers to stop the manufacturing and marketing of certain unapproved Fixed Dose Combination (FDC) drugs.
Read More
Eli Lilly launches Mounjaro in India for anti obesity treatment
Updated : 1 year, 4 months ago IST
Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro® is available in single-dose vials, with pricing set at Rs3,500 for a 2.5 mg vial and Rs4,375 for a 5 mg vial, leading to a monthly cost of Rs14,000-Rs17,500, depending on dosage.
Read More
CDSCO releases list of NSQ and spurious drugs for Nov 2024
Updated : 1 year, 6 months ago IST
Central Drugs Standard Control Organisation (CDSCO) on Friday released the list of Not of Standard Quality (NSQ) and Spurious drugs for the month of November 2024 on its portal.
Read More